1. Home
  2. SDGR vs TWST Comparison

SDGR vs TWST Comparison

Compare SDGR & TWST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SDGR
  • TWST
  • Stock Information
  • Founded
  • SDGR 1990
  • TWST 2013
  • Country
  • SDGR United States
  • TWST United States
  • Employees
  • SDGR N/A
  • TWST N/A
  • Industry
  • SDGR Biotechnology: Pharmaceutical Preparations
  • TWST Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • SDGR Health Care
  • TWST Health Care
  • Exchange
  • SDGR Nasdaq
  • TWST Nasdaq
  • Market Cap
  • SDGR 1.7B
  • TWST 1.8B
  • IPO Year
  • SDGR 2020
  • TWST 2018
  • Fundamental
  • Price
  • SDGR $21.62
  • TWST $29.30
  • Analyst Decision
  • SDGR Buy
  • TWST Buy
  • Analyst Count
  • SDGR 5
  • TWST 10
  • Target Price
  • SDGR $32.80
  • TWST $49.10
  • AVG Volume (30 Days)
  • SDGR 1.2M
  • TWST 1.3M
  • Earning Date
  • SDGR 05-07-2025
  • TWST 05-05-2025
  • Dividend Yield
  • SDGR N/A
  • TWST N/A
  • EPS Growth
  • SDGR N/A
  • TWST N/A
  • EPS
  • SDGR N/A
  • TWST N/A
  • Revenue
  • SDGR $230,492,000.00
  • TWST $347,680,000.00
  • Revenue This Year
  • SDGR $24.71
  • TWST $22.60
  • Revenue Next Year
  • SDGR $17.64
  • TWST $17.65
  • P/E Ratio
  • SDGR N/A
  • TWST N/A
  • Revenue Growth
  • SDGR 22.29
  • TWST 25.30
  • 52 Week Low
  • SDGR $16.60
  • TWST $27.12
  • 52 Week High
  • SDGR $28.47
  • TWST $60.90
  • Technical
  • Relative Strength Index (RSI)
  • SDGR 41.07
  • TWST 39.60
  • Support Level
  • SDGR $21.13
  • TWST $27.77
  • Resistance Level
  • SDGR $22.00
  • TWST $29.52
  • Average True Range (ATR)
  • SDGR 1.03
  • TWST 1.69
  • MACD
  • SDGR -0.23
  • TWST 0.06
  • Stochastic Oscillator
  • SDGR 30.11
  • TWST 34.06

About SDGR Schrodinger Inc.

Schrodinger Inc is a healthcare-based software company. Its operating segments are Software and Drug discovery. Through the Software segment, the company is focused on selling software to transform drug discovery across the life sciences industry and customers in materials science industries. In the Drug discovery segment, it is engaged in generating revenue from a portfolio of preclinical and clinical programs, internally and through collaborations. It generates revenue from the sales of software solutions and from research funding and milestone payments from its drug discovery collaborations.

About TWST Twist Bioscience Corporation

Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well-plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies and powers cost-effective, rapid high-throughput synthesis, enabling researchers to realize opportunities ahead rapidly. Geographically, it derives a majority of its revenue from the United States.

Share on Social Networks: